|
,TEST BANK FOR
| |
Pharmacology and the Nursing Process 8th Edition
| | | | | |
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
| | | | | | | |
Contents
Chapter |01: |The |Nursing |Process |and |Drug |Therapy.................................................................................... 4
Chapter |02: |Pharmacologic |Principles........................................................................................................... 8
Chapter |03: |Lifespan |Considerations .......................................................................................................... 14
Chapter |04: |Cultural, |Legal, |and |Ethical |Considerations............................................................................. 20
Chapter |05: |Medication |Errors: |Preventing |and |Responding ..................................................................... 26
Chapter |06: |Patient |Education |and |Drug |Therapy ...................................................................................... 29
Chapter |07: |Over-the-Counter |Drugs |and |Herbal |and |Dietary |Supplements ............................................. 34
Chapter |08: |Gene |Therapy |and |Pharmacogenomics .................................................................................. 38
Chapter |09: |Photo |Atlas |of |Drug |Administration ........................................................................................ 41
Chapter |10: |Analgesic |Drugs ....................................................................................................................... 50
Chapter |11: |General |and |Local |Anesthetics ............................................................................................... 57
Chapter |12: |Central |Nervous |System |Depressants |and |Muscle |Relaxants ................................................. 61
Chapter |13: |Central |Nervous |System |Stimulants |and |Related |Drugs ........................................................ 66
Chapter |14: |Antiepileptic |Drugs .................................................................................................................. 70
Chapter |15: |Antiparkinson |Drugs ................................................................................................................ 76
Chapter |16: |Psychotherapeutic |Drugs ........................................................................................................ 81
Chapter |17: |Substance |Abuse ..................................................................................................................... 88
Chapter |18: |Adrenergic |Drugs ..................................................................................................................... 93
Chapter |19: |Adrenergic-Blocking |Drugs ...................................................................................................... 98
Chapter |20: |Cholinergic |Drugs .................................................................................................................. 103
Chapter |21: |Cholinergic-Blocking |Drugs.................................................................................................... 108
Chapter |22: |Antihypertensive |Drugs ......................................................................................................... 113
Chapter |23: |Antianginal |Drugs .................................................................................................................. 119
Chapter |24: |Heart |Failure |Drugs ............................................................................................................... 125
Chapter |25: |Antidysrhythmic |Drugs .......................................................................................................... 131
Chapter |26: |Coagulation |Modifier |Drugs .................................................................................................. 137
Chapter |27: |Antilipemic |Drugs .................................................................................................................. 143
,Chapter |28: |Diuretic |Drugs ........................................................................................................................ 148
Chapter |29: |Fluids |and |Electrolytes .......................................................................................................... 154
Chapter |30: |Pituitary |Drugs ....................................................................................................................... 160
Chapter |31: |Thyroid |and |Antithyroid |Drugs ............................................................................................. 163
Chapter |32: |Antidiabetic |Drugs ................................................................................................................. 168
Chapter |33: |Adrenal |Drugs ........................................................................................................................ 177
Chapter |34: |Women’s |Health |Drugs ......................................................................................................... 181
Chapter |35: |Men’s |Health |Drugs............................................................................................................... 188
Chapter |36: |Antihistamines, |Decongestants, |Antitussives, |and |Expectorants ......................................... 193
Chapter |37: |Respiratory |Drugs .................................................................................................................. 198
Chapter |38: |Antibiotics |Part |1 ................................................................................................................... 204
Chapter |39: |Antibiotics |Part |2 ................................................................................................................... 211
Chapter |40: |Antiviral |Drugs ....................................................................................................................... 216
Chapter |41: |Antitubercular |Drugs ............................................................................................................. 221
Chapter |42: |Antifungal |Drugs .................................................................................................................... 226
Chapter |43: |Antimalarial, |Antiprotozoal, |and |Anthelmintic |Drugs ........................................................... 231
Chapter |44: |Anti-inflammatory |and |Antigout |Drugs ................................................................................ 236
Chapter |45: |Antineoplastic |Drugs |Part |1: |Cancer |Overview |and |Cell |Cycle–Specific |Drugs ..................... 242
Chapter |46: |Antineoplastic |Drugs |Part |2: |Cell |Cycle–Nonspecific |Drugs |and |Miscellaneous |Drugs......... 248
Chapter |47: |Biologic |Response–Modifying |and |Antirheumatic |Drugs ...................................................... 253
Chapter |48: |Immunosuppressant |Drugs ................................................................................................... 258
Chapter |49: |Immunizing |Drugs.................................................................................................................. 263
Chapter |50: |Acid-Controlling |Drugs .......................................................................................................... 268
Chapter |51: |Bowel |Disorder |Drugs ........................................................................................................... 274
Chapter |52: |Antiemetic |and |Antinausea |Drugs ........................................................................................ 281
Chapter |53: |Vitamins |and |Minerals .......................................................................................................... 286
Chapter |54: |Anemia |Drugs ........................................................................................................................ 292
Chapter |55: |Nutritional |Supplements ....................................................................................................... 299
Chapter |56: |Dermatologic |Drugs ............................................................................................................... 304
Chapter |57: |Ophthalmic |Drugs .................................................................................................................. 310
Chapter |58: |Otic |Drugs .............................................................................................................................. 315
, Chapter 01: The Nursing Process and Drug Therapy
| | | | | | |
MULTIPLE |CHOICE
1. The |nurse |is |writing |a |nursing |diagnosis |for |a |plan |of |care |for |a |patient |who |has |been |newly
|diagnosed |with |type |2 |diabetes. |Which |statement |reflects |the |correct |format |for |a |nursing
|diagnosis?
a. Anxiety
b. Anxiety |related |to |new |drug |therapy
c. Anxiety|related |to |anxious |feelings |about |drug |therapy, |as |evidenced |by |statements
|such |as |“I’m |upset |about |having |to |test |my |blood |sugars.”
d. Anxiety|related |to |new |drug |therapy, |as |evidenced |by |statements |such |as |“I’m
|upset |about |having |to |test |my |blood |sugars.”
ANS: | D
Formulation |of |nursing |diagnoses |is |usually |a |three-step |process. |“Anxiety” |is |missing |the |“related
|to” |and |“as |evidenced |by” |portions |of |defining |characteristics. |“Anxiety |related |to |new |drug
|therapy” |is |missing |the |“as |evidenced |by” |portion |of |defining |characteristics. |The |statement
|beginning |“Anxiety |related |to |anxious |feelings” |is |incorrect |because |the |“related |to” |section |is
|simply |a |restatement |of |the |problem |“anxiety,” |not |a |separate |factor |related |to |the |response.
DIF: COGNITIVE |LEVEL: |Understanding |(Comprehension) REF: |p. |7
|TOP: | NURSING |PROCESS: |Nursing |Diagnosis
MSC: | NCLEX: |Safe |and |Effective |Care |Environment: |Management |of |Care
2. The |patient |is |to |receive |oral |guaifenesin |(Mucinex) |twice |a |day. |Today, |the |nurse |was |busy |and
gave |the |medication |2 |hours |after |the |scheduled |dose |was |due. |What |type |of |problem |does |this
|
represent?
|
a. “Right |time”
b. “Right |dose”
c. “Right |route”
d. “Right |medication”
ANS: | A
“Right |time” |is |correct |because |the |medication |was |given |more |than |30 |minutes |after |the |scheduled
|dose |was |due. |“Dose” |is |incorrect |because |the |dose |is |not |related |to |the |time |the |medication
|administration |is |scheduled. |“Route” |is |incorrect |because |the |route |is |not |affected. |“Medication” |is
|incorrect |because |the |medication |ordered |will |not |change.
DIF: COGNITIVE |LEVEL: |Applying |(Application) REF: |p. |11
|TOP: | NURSING |PROCESS: |Implementation
MSC: | NCLEX: |Safe |and |Effective |Care |Environment: |Safety |and |Infection |Control
3. The |nurse |has |been |monitoring |the |patient’s |progress |on |a |new |drug |regimen |since |the |first |dose
and |documenting |the |patient’s |therapeutic |response |to |the |medication. |Which |phase |of |the
|
nursing |process |do |these |actions |illustrate?
|
a. Nursing |diagnosis